[go: up one dir, main page]

SV1998000040A - Composiciones farmaceuticas ref. pu3210/sv - Google Patents

Composiciones farmaceuticas ref. pu3210/sv

Info

Publication number
SV1998000040A
SV1998000040A SV1998000040A SV1998000040A SV1998000040A SV 1998000040 A SV1998000040 A SV 1998000040A SV 1998000040 A SV1998000040 A SV 1998000040A SV 1998000040 A SV1998000040 A SV 1998000040A SV 1998000040 A SV1998000040 A SV 1998000040A
Authority
SV
El Salvador
Prior art keywords
pharmaceutical compositions
compositions ref
ref
lamivudina
hidroximetilo
Prior art date
Application number
SV1998000040A
Other languages
English (en)
Inventor
Ngoc-Anh Thi Nguyen
Warren Michael Casey
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706295.4A external-priority patent/GB9706295D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SV1998000040A publication Critical patent/SV1998000040A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A FORMULACIONES FARMACEUTICAS, NOVEDOSAS QUE CONTIENEN (2R,CIS) -4--AMINO-1-(2-HIDROXIMETILO-1,3-OXATIOLAN-5-IL) -(1H)-PIRIMIDIN-2-ONA ((-)-2¿,3¿-DEDESOXI,3TIACIRIDINA, EPIVIR, LAMIVUDINA) Y SU USO EN LA TERAPIA MEDICA
SV1998000040A 1997-03-24 1998-03-20 Composiciones farmaceuticas ref. pu3210/sv SV1998000040A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation

Publications (1)

Publication Number Publication Date
SV1998000040A true SV1998000040A (es) 1999-03-16

Family

ID=26311267

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1998000040A SV1998000040A (es) 1997-03-24 1998-03-20 Composiciones farmaceuticas ref. pu3210/sv

Country Status (39)

Country Link
US (1) US6004968A (es)
EP (1) EP0969815B1 (es)
JP (1) JP3264937B2 (es)
KR (1) KR100484695B1 (es)
CN (1) CN1191061C (es)
AP (1) AP1141A (es)
AR (1) AR011697A1 (es)
AT (1) ATE295150T1 (es)
AU (1) AU728461B2 (es)
BG (1) BG64690B1 (es)
BR (1) BR9808060B1 (es)
CA (1) CA2286126C (es)
CO (1) CO4980849A1 (es)
CY (1) CY2569B1 (es)
CZ (1) CZ298008B6 (es)
DE (1) DE69830154T2 (es)
EA (1) EA001990B1 (es)
EE (1) EE03996B1 (es)
ES (1) ES2239802T3 (es)
HN (1) HN1998000045A (es)
HR (1) HRP980154B1 (es)
HU (1) HU225600B1 (es)
ID (1) ID29294A (es)
IL (1) IL131917A0 (es)
IS (1) IS2515B (es)
MY (1) MY116242A (es)
NO (1) NO326719B1 (es)
NZ (1) NZ337798A (es)
PA (1) PA8449301A1 (es)
PE (1) PE61699A1 (es)
PL (1) PL190505B1 (es)
PT (1) PT969815E (es)
RS (1) RS49772B (es)
SI (1) SI0969815T1 (es)
SK (1) SK283417B6 (es)
SV (1) SV1998000040A (es)
TW (1) TW536403B (es)
UY (1) UY24930A1 (es)
WO (1) WO1998042321A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2258956A1 (en) 1996-06-25 1997-12-31 Glaxo Group Limited Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
US6018044A (en) * 1998-01-02 2000-01-25 Roche Vitamins Inc. Light screening compositions
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
JP2003039582A (ja) * 2001-07-19 2003-02-13 Three M Innovative Properties Co 湿潤防滑性シート及び湿潤防滑構造体
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
MY131488A (en) * 2002-04-08 2007-08-30 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
CA2517310C (en) * 2003-02-28 2015-11-24 Chugai Seiyaku Kabushiki Kaisha Stabilized protein-containing formulations comprising a poloxamer
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
RU2587782C1 (ru) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Стабильная фармацевтическая композиция ламивудина

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5587480A (en) 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
HN1998000045A (es) 1999-03-19
PA8449301A1 (es) 2000-05-24
BR9808060B1 (pt) 2009-05-05
RS49772B (sr) 2008-06-05
AU728461B2 (en) 2001-01-11
WO1998042321A2 (en) 1998-10-01
HRP980154A2 (en) 1998-12-31
BG103818A (en) 2000-06-30
KR20010005624A (ko) 2001-01-15
CA2286126A1 (en) 1998-10-01
YU47799A (sh) 2002-06-19
CZ340399A3 (cs) 2000-04-12
IL131917A (en) 2001-01-11
BR9808060A (pt) 2000-03-08
NO994619L (no) 1999-11-23
TW536403B (en) 2003-06-11
HUP0002982A3 (en) 2001-12-28
SK129999A3 (en) 2000-07-11
WO1998042321A3 (en) 1999-01-07
PL190505B1 (pl) 2005-12-30
NO326719B1 (no) 2009-02-02
NO994619D0 (no) 1999-09-23
PE61699A1 (es) 1999-07-08
ATE295150T1 (de) 2005-05-15
CN1255849A (zh) 2000-06-07
EE03996B1 (et) 2003-04-15
PL336038A1 (en) 2000-06-05
SI0969815T1 (es) 2005-08-31
EP0969815A2 (en) 2000-01-12
AR011697A1 (es) 2000-08-30
ES2239802T3 (es) 2005-10-01
IS5184A (is) 1999-09-17
SK283417B6 (sk) 2003-07-01
CY2569B1 (en) 2008-07-02
CO4980849A1 (es) 2000-11-27
AU7208498A (en) 1998-10-20
EP0969815B1 (en) 2005-05-11
US6004968A (en) 1999-12-21
EA001990B1 (ru) 2001-10-22
NZ337798A (en) 2001-03-30
EA199900757A1 (ru) 2000-08-28
KR100484695B1 (ko) 2005-04-22
ID29294A (id) 2001-08-16
DE69830154T2 (de) 2005-10-13
MY116242A (en) 2003-12-31
HK1022853A1 (en) 2000-08-25
PT969815E (pt) 2005-07-29
JP3264937B2 (ja) 2002-03-11
AP9901657A0 (en) 1999-09-30
JP2001501974A (ja) 2001-02-13
CA2286126C (en) 2003-08-12
HU225600B1 (en) 2007-05-02
HUP0002982A2 (hu) 2001-01-29
DE69830154D1 (de) 2005-06-16
IL131917A0 (en) 2001-03-19
AP1141A (en) 2003-01-29
EE9900440A (et) 2000-04-17
BG64690B1 (bg) 2005-12-30
CN1191061C (zh) 2005-03-02
UY24930A1 (es) 2000-10-31
CZ298008B6 (cs) 2007-05-23
IS2515B (is) 2009-06-15
HRP980154B1 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
DE69508837D1 (de) Protein enthaltende stabilisierte Formulierung und Dosierungskit
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR9915247B1 (pt) compostos biaromáticos análogos da vitamina d, seus usos, composição farmacêutica e composição cosmética contendo os mesmos, e uso da composição cosmética.
MX9205905A (es) Composiciones cosmeticas tipo gel
ES2130575T3 (es) Composiciones inmunogenicas mejoradas contra la gastrina 17 humana.
TR199802423T2 (xx) Konsantre antikor terkibi.
ES2173978T3 (es) Utilizacion de un alcohol graso insaturado.
SV1997000049A (es) Conjugados de interferones ref. 12614 sv
ID28003A (id) Turunan-turunan adamantana
KR960702303A (ko) 항억제제 제형 (Antidepressant Dosage Form)
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
DE68901417D1 (de) Pharmazeutische zusammensetzung.
MX9203480A (es) Formulaciones medicinales en aereosol.
SV1998000040A (es) Composiciones farmaceuticas ref. pu3210/sv
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
ES2174199T3 (es) Utilizacion de un poliholosido para estimular las defensas inmunitarias.
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
ES2187489T3 (es) Composiciones farmaceuticas a base de diclofenac.
DE69117303D1 (de) Zusammensetzung mit psyllium
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
PH27567A (en) Topical compositions
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions

Legal Events

Date Code Title Description
FG Grant